Sign In

Serena Kimi Perna, MD

Clinical Development Lead - Cell Therapy

Serena Kimi Perna, MD, is currently the Clinical Development Lead for Cell Therapy at Bristol Myers Squibb, a position she has held since August 2021. Based in Princeton, New Jersey, she has a robust background in clinical development, particularly focusing on innovative therapies for hematological malignancies.

Professional Experience

  • Bristol Myers Squibb
    • Clinical Development Lead (August 2021 - Present)
    • Senior Clinical Trial Lead (December 2016 - April 2019)
    • Medical Director (April 2016 - December 2016)
  • Autolus Ltd.
    • Executive Director (April 2019 - August 2021)

Education

Dr. Perna received her medical degree from the Libera Università Vita-Salute San Raffaele.

Her career reflects significant expertise in leading clinical trials and developing therapies, contributing to advancements in cancer treatment.

Highlights

Mar 15 · linkedin

Very excited that this new treatment modality is now available for pts with R/R CLL/SLL.

Extremely proud to be part of such an amazing team!

Nov 9 · linkedin

Come and join our amazing team to bring new cell therapies to patients with hematological malignancies!!

Related Questions

What are some of the key projects Serena Kimi Perna has led at Bristol Myers Squibb?
How did Serena Kimi Perna transition from Autolus Ltd. to Bristol Myers Squibb?
What is Serena Kimi Perna's educational background?
What are the main responsibilities of a Clinical Development Lead at Bristol Myers Squibb?
How has Serena Kimi Perna contributed to the field of cell therapy?
Serena Kimi Perna, MD
Serena Kimi Perna, MD, photo 1
Serena Kimi Perna, MD, photo 2
Add to my network

Location

Princeton, New Jersey, United States